Mr David Lancaster

David Lancaster

Updates

Healthcare & Life Sciences

Importance of patents in biosimilars industry
United Kingdom | 10 March 2021

Over the next few years, some of the best-known biologic medicines will lose patent protection, paving the way for biosimilar medicines to enter the UK market. This article discusses some innovative IP strategies which may be available in the United Kingdom to successfully compete and overcome barriers to market entry.

Intellectual Property

Importance of patents in biosimilars industry
United Kingdom | 15 March 2021

Over the next few years, some of the best-known biologic medicines will lose patent protection, paving the way for biosimilar medicines to enter the UK market. This article discusses some innovative IP strategies which may be available in the United Kingdom to successfully compete and overcome barriers to market entry.